These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30534252)

  • 1. Two-week administration of rivaroxaban resolved left atrial thrombus.
    Kato T; Yasaka M; Yabuki T; Adachi T; Toyoda S; Inoue T
    J Cardiol Cases; 2014 Dec; 10(6):238-240. PubMed ID: 30534252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Li X; Ning M; Lyu J; Yang Y; Liu XH; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):606-610. PubMed ID: 30139010
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
    Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracardiac Thrombus Following Rivaroxaban Treatment in a Patient with Atrial Fibrillation Associated with Rheumatic Heart Disease.
    Ohara H; Yamamoto S; Nagano K; Hashikawa K
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104325. PubMed ID: 31427189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced smoke-like echo and resolved thrombus in the left atrium with rivaroxaban therapy in an acute cardioembolic stroke patient.
    Saito S; Tomita H; Kimura Y; Shiroto H; Hagii J; Metoki N; Hitomi H; Kamada T; Osanai T; Okumura K; Yasujima M
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1747-9. PubMed ID: 24725815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of left ventricular thrombus by rivaroxaban.
    Padilla Pérez M; Salas Bravo D; Garcelán Trigo JA; Vazquez Ruiz de Castroviejo E; Torres Llergo J; Lozano Cabezas C; Fernández Guerrero JC
    Future Cardiol; 2014 May; 10(3):333-6. PubMed ID: 24976470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; van Eickels M; Cohen A;
    Am Heart J; 2016 Aug; 178():126-34. PubMed ID: 27502860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
    Yang Y; Du X; Dong J; Ma C
    Am J Med Sci; 2019 Oct; 358(4):273-278. PubMed ID: 31543101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA).
    Miyazawa K; Pastori D; Hammerstingl C; Cappato R; Meng IL; Kramer F; Cohen A; Schulz A; Eickels MV; Lip GYH; Marin F
    Ann Med; 2018 Sep; 50(6):511-518. PubMed ID: 29956554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban.
    Gaznabi S; Abugroun A; Mahbub H; Campos E
    Case Rep Cardiol; 2019; 2019():6076923. PubMed ID: 31093379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A; Katz WE; Genuardi MV; Bhonsale A; Jain SK; Kancharla K; Saba S; Shalaby AA; Voigt AH; Wang NC
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
    Szegedi N; Gellér L; Tahin T; Merkely B; Széplaki G
    Orv Hetil; 2016 Jan; 157(4):154-6. PubMed ID: 26772828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rivaroxaban-resistant right ventricular thrombus, successfully treated with vitamin K antagonist in a patient with dilated cardiomyopathy].
    Elikowski W; Małek-Elikowska M; Słomczyński M; Ganowicz-Kaatz T; Bolewski A; Skrzywanek P
    Pol Merkur Lekarski; 2016 Nov; 41(245):238-242. PubMed ID: 27883351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
    Ezekowitz MD; Cappato R; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca MI; Vardas PE; Kirchhof P; Hohnloser SH; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M
    Am Heart J; 2014 May; 167(5):646-52. PubMed ID: 24766973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.
    Watanabe T; Shinoda Y; Ikeoka K; Minamisaka T; Fukuoka H; Inui H; Hoshida S
    Intern Med; 2017; 56(15):1977-1980. PubMed ID: 28768967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report.
    Scarano M; Casale M; Mantini C; Imbalzano E; Consorti C; Clemente D; Dattilo G
    J Med Case Rep; 2017 Apr; 11(1):97. PubMed ID: 28390428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.